From Rainforest Discovery to FDA Pipeline: Immune Modulation Advances a 30-Year Scientific Journey Toward Parkinson's Innovation
- Posted on March 30, 2026
- By International Business Times
- 7 Views
From Rainforest Discovery to FDA Pipeline: Immune Modulation Advances a 30-Year Scientific Journey Toward Parkinson's Innovation
Immune Modulation, Inc., a California-based biotech company founded in 1995, is translating a plant-derived compound into a drug candidate now being prepared for regulatory pathways in Parkinson's disease.
